Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Ratio Therapeutics Appoints Jacob Hesterman, Ph.D., as Chief Data Officer
Ratio Therapeutics Inc., a pharmaceutical company that employs a suite of innovative technologies to develop […]
Tridek-one Closes a €16 Million Financing Round to Develop First-in-class Immune Checkpoint Agonists
Tridek-One SAS (the ‘Company’), a leading biotech start-up specialized in the research and development of […]
Neuron23 and QIAGEN Announce Collaboration to Develop the First Next-Generation Sequencing Companion Diagnostic for Novel Parkinson's Disease Drug
Neuron23™ Inc., an early stage biotechnology company focused on developing precision medicines for genetically defined […]
Gameto Announces New Funding and Preclinical Development Partnerships with Leading Global Fertility Clinics
Gameto, a biotechnology company using cell engineering to develop therapeutics for diseases of the female […]
Biolojic Design Appoints Ronald Herbst, Ph.D., as Chief Scientific Officer
Biolojic Design, a pioneer in the use of artificial intelligence (AI) in antibody design, today announced […]
Novo Nordisk and Microsoft Collaborate to Accelerate Drug Discovery and Development Using Big Data and Artificial Intelligence
Novo Nordisk and Microsoft have entered a new strategic collaboration to combine Microsoft’s computational services, […]
Monogram Health Donates $2.5M to University of Pennsylvania for Clinical Research Partnership Aimed at Improving Outcomes for People with Chronic Kidney Disease
Monogram Health, the leading value-based specialty provider of in-home nephrology, primary care, and benefit management […]
Strata Oncology Announces Expansion of Clinical Collaboration with Pfizer for Strata PATH Trial into Early-Stage Cancer
Strata Oncology, Inc. a next-generation precision oncology company enabling smarter and earlier cancer treatment, today […]
Prolifagen Therapeutics Appoints M. Alexander Shaw, PhD, as Chief Executive Officer
Prolifagen Therapeutics, a biotech startup developing medicines for cardiac regeneration, has appointed M. Alexander Shaw, PhD, […]
Vyriad, Inc. Appoints Scott Beck as Chief Operating Officer
Vyriad, Inc., a biotechnology company developing oncolytic virus therapies to treat a wide range of […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more